Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 10, 2014, Pages 4225-4231

  Cihan, Yasemin Benderli ^a   Arslan, Alaettin ^a   Cetindag, Mehmet Faik ^b   Mutlu, Hasan ^c  

^a Kayseri Education and Research Hospital ^*  (Turkey)

^b Acibadem Hospital   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Blood parameters; Breast cancer; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGE; AGED; BLOOD; BLOOD CELL COUNT; BREAST NEOPLASMS; BREAST TUMOR; CYTOLOGY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; METASTASIS; MIDDLE AGED; MORTALITY; NEUTROPHIL; PATHOLOGY; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903549095     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.10.4225     Document Type: Article

References (20)

1. Afsharfard A, Mozaffar M, Orang E, Tahmasbpour E (2013). Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev, 14, 6905-11.
2. Aggarwal B, Gehlot P (2009). Inflammation and cancer: how friendly is the relationship for cancer patients? Current Opinion in Pharmacology, 9, 351-69.
3. Azab B, Bhatt VR, Phookan J, et al (2012). Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients. Ann Surg Oncol, 19, 217-24.
4. Azab B, Shah N, Radbel J, et al (2013). Pretreatment neutrophil/ lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol, 30, 432.
5. Bachelot T, Ray-Coquard I, Menetrier-Caux C, et al (2003). Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer, 88, 1721-6.
6. Ceber E, Mermer G, Okcin F, et al (2013). Breast cancer risk and early diagnosis applications in Turkish women aged 50 and over. Asian Pac J Cancer Prev, 14, 5877-82.
7. Engin H, Bilir C, Tekin IO (2013). Prognostic significance of peripheral blood flow cytometry parameters in patients with non-metastatic breast cancer. Asian Pac J Cancer Prev, 14, 7645-9.
8. Gorelik E, Landsittel DP, Marrangoni AM, et al (2005). Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Bio-markers Prev, 14, 981-7.
9. Harada A, Sekido N, Akahoshi T, et al (1994). Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol, 56, 559-64.
10. Hu Q, Chen WX, Zhong SL, et al (2013). Current progress in the treatment of metaplastic breast carcinoma. Asian Pac J Cancer Prev, 14, 6221-5.
11. Kassim SK, El-Salahy EM, Fayed ST, et al (2004). Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem, 37, 363-9.
12. Lyon DE, McCain NL, Walter J, Schubert C (2008). Cytokine comparisons between women with breast cancer and women with a negative breast biopsy. Nurs Res, 57, 51-8.
13. Pierce BL, Ballard-Barbash R, Berstein L, et al (2009). Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol, 21, 3437-44.
14. Proctor M, Morrison D, Talwar D, et al (2011). A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer, 47, 2633-41.
15. Pusztai L, Mendoza TR, Reuben JM, et al (2004). Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine, 25, 94-102.
16. Kusumanto YH , Dam WA, Hospers GA, Meijer C, Mulder NH (2003). Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis, 6, 283-7.
17. Sezer H, Yilmaz M, Gurler H, Koyuncu A (2011). Breast cancer risk factors in Turkey: a hospital-based case-control study. Asian Pac J Cancer Prev, 12, 2317-22.
18. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
19. Sotiriou C, Neo SY, McShane LM, et al (2003). Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA, 100, 10393-8.
20. Tenesa A, Theodoratou E, Din FV, et al (2010). Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis. Clin Cancer Res, 16, 3754-9.